Mankind Pharma, which started off with an investment of Rs 50 lakh, has become the sixth largest pharma company with revenue of Rs 3,400 crore this year. RC Juneja, founder & chairman, Mankind Pharma, talks about the company’s growth, why it is not listed and delivering medicines at affordable prices.
Mankind Pharma was started in 1995 with an investment of merely Rs 50 lakh and only 20 employees. Today, we are among the top five fastest growing pharmaceutical companies of India with an employee base of more than 10,000 and heading towards a turnover of Rs 3,400 crore.
We aspire to aid the community in leading a healthy life through two parallel objectives: formulating, developing & commercialising medicines and delivering affordable & accessible medication that satisfies urgent medical needs.
Our strong portfolio of businesses, geographies and products ranging from pharma to popular OTC & FMCG brands — Unwanted72, PregaNews, Kustody, Adiction, Gas-O-Fast, and Manforce condoms provide us the strategic benefits of integration that allow us to perform best in an increasingly competitive market.
In 2010, Mankind launched its first overseas market, SriLanka and we are expanding the horizon in Vietnam, Philippines, Myanmar, African market, CIS and other regulated and semi-regulated markets by 2015.
Mankind Pharma was started in 1995 with an investment of merely Rs 50 lakh and only 20 employees. Today, we are among the top five fastest growing pharmaceutical companies of India with an employee base of more than 10,000 and heading towards a turnover of Rs 3,400 crore.
No comments:
Post a Comment